Korea’s Clinical Trial Landscape In 2022: Approvals Fall To Pre-COVID Levels

MSD, Janssen, Chong Kun Dang, Daewoong Top Sponsors

The Pink Sheet takes an infographic look at South Korea's clinical trial trends in 2022 to illustrate how the country's biopharma R&D is developing and how activities are recovering in the post-pandemic situation. One key takeaway is that approvals for trial starts have fallen back to pre-COVID levels, suggesting a falling off of activity related to drugs and vaccines for the virus.

clinical trials — Clinical Trials For Both Domestic And Foreign Drugs Drop • Source: Shutterstock

The number of clinical trial approvals across all development phases in South Korea in 2022 sank to the level of before the COVID-19 pandemic in 2019 - but despite the drop, the country’s global ranking in terms of number of such permissions improved a notch, marking its best-ever placing.

According to the Ministry of Food and Drug Safety’s data for clinical trial approvals during the calendar year, the country...